Clinical Studies

Clinical Studies

The benefits of Bios Life have been clinically proven  in 8 scientific trials and clinical studies  at some of the top universities, hospitals, and research institutions around the world,  including the Cleveland Clinic,  recognized as the leading heart research institution  in the United States. On average,  Bios Life reduces bad cholesterol (LDL) by 31%  in only eight weeks and  over 50% in participants with very high LDL levels.  It improves good cholesterol levels (HDL) by an average 29%  in the same eight weeks and  up to 80% in those with very low HDL levels.  Continued use showed further improvement in both LDL and HDL levels.  It also reduces triglyceride levels an average of 40%.  There is no known clinically proven drug or natural product in the world that  offers these three combined benefits  to help reduce one’s risk of cardiovascular disease.  Unlike prescription drugs,  Bios Life is a true cholesterol optimization product. In addition,  a recent study presented  at the American Heart Association Annual Conference  concluded Bios Life reduced the post-prandial glucose levels 28% and HbA1c levels 15%; indicating Bios Life provides a natural option to improve diabetes management. Details about the numerous clinical studies can be found at www.unicityscience.org.